Terlipressin: Serious or fatal respiratory failure and sepsis/septic shock in patients with type 1 hepatorenal syndrome (type 1 HRS)
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Active substance |
terlipressin
|
| Therapeutic area (MeSH) |
Vasopressins
|
| Procedure number |
EMEA/H/A-31/1514
|
| Regulatory outcome |
Variation
|
| DHPC type |
Referral - Article 31
|
| Referral name |
Terlipressin-containing medicinal products indicated in the treatment of hepatorenal syndrome
|
| Human ATC code |
H01BA04
|
| Dissemination date |
01/12/2022
|
| Related medicines |
Glypressin, Terlipressin Acetate and Variquel
|